Infantile fibrosarcoma treated with postoperative vincristine and dactinomycin

Hiroki Yoshihara, Yuri Yoshimoto, Yosuke Hosoya, Daisuke Hasegawa, Takafumi Kawano, Akiko Sakoda, Hajime Okita, Atsushi Manabe

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Infantile fibrosarcoma is a non-rhabdomyosarcoma soft-tissue sarcoma that occurs in infancy and which has a relatively good prognosis. A vincristine and dactinomycin (VA) regimen has been shown to be effective, although the duration of chemotherapy has not been well defined. We describe the case of a 4-month-old boy with a mass at the left dorsum of the foot who was diagnosed with infantile fibrosarcoma after resection of the tumor, the margin of which was macroscopically positive. VA treatment was carried out with careful monitoring of response and adverse effects. Pancytopenia was seen during the second cycle, and therapy was reduced thereafter. The treatment was continued for 38 weeks (12 cycles). There was no functional impairment, and no evidence of recurrence at 18 months after therapy.

Original languageEnglish
Pages (from-to)371-374
Number of pages4
JournalPediatrics International
Issue number3
Publication statusPublished - 2017 Mar 1


  • adjuvant chemotherapy
  • dactinomycin
  • fibrosarcoma
  • infant
  • vincristine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Infantile fibrosarcoma treated with postoperative vincristine and dactinomycin'. Together they form a unique fingerprint.

Cite this